F10 and obesity disorder: In small prospective studies, medical chart reviews, and pooled analyses, weight-based pharmacologic thromboprophylaxis was safe and helped achieve desired serum levels of anti-factor Xa activity in patients with obesity (61, 64, 85, 86).